Advertisement
Screener

LISATA THERAPEUTICS, INC. (LSTA) Retention Payable

2.8 / 5 stars · 68/120 Roast Me

LISATA THERAPEUTICS, INC. Retention Payable

LISATA THERAPEUTICS, INC. (LSTA) had Retention Payable of $382.00 thousand as of 2019-06-30, per its 10-Q filed 2019-08-08.

Discontinued › Notes

us-gaap:RetentionPayable · last filed 2019-08-08

  • 2019-06-30: Retention Payable $382.00K.
  • 2019-03-31: Retention Payable $396.00K.
  • 2018-12-31: Retention Payable $0.00.
  • 2018-09-30: Retention Payable $0.00.
Period endRetention Payable
2019-06-30$382.00K
10-Q · filed 2019-08-08
2019-03-31$396.00K
10-Q · filed 2019-05-09
2018-12-31$0.00
10-Q · filed 2019-08-08
2018-09-30$0.00
10-Q · filed 2018-11-08
2018-06-30$0.00
10-Q · filed 2018-08-09
2018-03-31$2.23M
10-Q · filed 2018-05-10
2017-12-31$2.23M
10-Q · filed 2018-11-08
2017-09-30$2.23M
10-Q · filed 2017-11-09
2017-06-30$2.23M
10-Q · filed 2017-08-10
2016-12-31$0.00
10-K · filed 2018-03-22

Similar stocks

Stock NameCountryMarket CapPE Ratio
Vistagen Therapeutics, Inc. (VTGN)United States$0.013B-0.14
MUSTANG BIO, INC. (MBIO)United States$0.013B
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36
Vyome Holdings, Inc (HIND)United States$0.014B-1.38
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B
Tempest Therapeutics, Inc. (TPST)United States$0.013B
Aspire Biopharma Holdings, Inc. (ASBP)United States$0.012B-0.60
ACTUATE THERAPEUTICS, INC. (ACTU)United States$0.015B
BIOVIE INC. (BIVI)United States$0.012B